Cargando…

Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)

BACKGROUND: The metabolic syndrome (MetSyn) places individuals at increased risk for type 2 diabetes and cardiovascular disease. Prevalence rates of the population of the MetSyn are still scarce. Moreover, the impact of different definitions of the MetSyn on the prevalence is unclear. Aim here is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Moebus, Susanne, Hanisch, Jens Ulrich, Aidelsburger, Pamela, Bramlage, Peter, Wasem, Jürgen, Jöckel, Karl-Heinz
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2031874/
https://www.ncbi.nlm.nih.gov/pubmed/17822558
http://dx.doi.org/10.1186/1475-2840-6-22
_version_ 1782136798053400576
author Moebus, Susanne
Hanisch, Jens Ulrich
Aidelsburger, Pamela
Bramlage, Peter
Wasem, Jürgen
Jöckel, Karl-Heinz
author_facet Moebus, Susanne
Hanisch, Jens Ulrich
Aidelsburger, Pamela
Bramlage, Peter
Wasem, Jürgen
Jöckel, Karl-Heinz
author_sort Moebus, Susanne
collection PubMed
description BACKGROUND: The metabolic syndrome (MetSyn) places individuals at increased risk for type 2 diabetes and cardiovascular disease. Prevalence rates of the population of the MetSyn are still scarce. Moreover, the impact of different definitions of the MetSyn on the prevalence is unclear. Aim here is to assess the prevalence of the MetSyn in primary health care and to investigate the impact of four different definitions of the MetSyn on the determined prevalence with regard to age, gender and socio-economic status. METHODS: The German-wide cross-sectional study was conducted during two weeks in October 2005 in 1.511 randomly selected general practices. Blood samples were analyzed, blood pressure and waist circumference assessed, data on lifestyle, medication, chronic disorders, and socio-demographic characteristics collected. MetSyn prevalence was estimated according to the definitions of NCEP ATP III (2001), AHA/NHLBI (2004, 2005), and IDF (2005). Descriptive statistics and prevalence rate ratios using the PROG GENMOD procedure, were calculated. Cohen's kappa was used as measure for interreliability between the different prevalence estimates. RESULTS: Data of 35,869 patients (age range: 18–99, women 61.1%) were included. The prevalence was lowest using the NCEP ATP III- (all: 19.8%, men 22.7%, women: 18.0%), highest according to the IDF-definition (32.7%, 40.3%, 28.0%). The increase in prevalence with recent definitions was more pronounced for men than for women, and was particularly high for men and women aged 60–79 years. The IDF-definition resulted in a higher prevalence especially in those with the highest educational status. Agreement (kappa) between the NCEP ATP III- and IDF-definition was 0.68 (men 0.61, women 0.74), between the updated the AHA/NHLBI- (2005) and IDF-definition 0.85 (men 0.79, women 0.89). CONCLUSION: The prevalence of metabolic syndrome is associated with age, gender, and educational status and increases considerably with each newly published definition. Our data highlight the need for a better evidence regarding thresholds of the components of the metabolic syndrome, especially with regard to the IDF-definition – according to which in some populations a majority of subjects are diagnosed with the metabolic syndrome.
format Text
id pubmed-2031874
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20318742007-10-17 Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS) Moebus, Susanne Hanisch, Jens Ulrich Aidelsburger, Pamela Bramlage, Peter Wasem, Jürgen Jöckel, Karl-Heinz Cardiovasc Diabetol Original Investigation BACKGROUND: The metabolic syndrome (MetSyn) places individuals at increased risk for type 2 diabetes and cardiovascular disease. Prevalence rates of the population of the MetSyn are still scarce. Moreover, the impact of different definitions of the MetSyn on the prevalence is unclear. Aim here is to assess the prevalence of the MetSyn in primary health care and to investigate the impact of four different definitions of the MetSyn on the determined prevalence with regard to age, gender and socio-economic status. METHODS: The German-wide cross-sectional study was conducted during two weeks in October 2005 in 1.511 randomly selected general practices. Blood samples were analyzed, blood pressure and waist circumference assessed, data on lifestyle, medication, chronic disorders, and socio-demographic characteristics collected. MetSyn prevalence was estimated according to the definitions of NCEP ATP III (2001), AHA/NHLBI (2004, 2005), and IDF (2005). Descriptive statistics and prevalence rate ratios using the PROG GENMOD procedure, were calculated. Cohen's kappa was used as measure for interreliability between the different prevalence estimates. RESULTS: Data of 35,869 patients (age range: 18–99, women 61.1%) were included. The prevalence was lowest using the NCEP ATP III- (all: 19.8%, men 22.7%, women: 18.0%), highest according to the IDF-definition (32.7%, 40.3%, 28.0%). The increase in prevalence with recent definitions was more pronounced for men than for women, and was particularly high for men and women aged 60–79 years. The IDF-definition resulted in a higher prevalence especially in those with the highest educational status. Agreement (kappa) between the NCEP ATP III- and IDF-definition was 0.68 (men 0.61, women 0.74), between the updated the AHA/NHLBI- (2005) and IDF-definition 0.85 (men 0.79, women 0.89). CONCLUSION: The prevalence of metabolic syndrome is associated with age, gender, and educational status and increases considerably with each newly published definition. Our data highlight the need for a better evidence regarding thresholds of the components of the metabolic syndrome, especially with regard to the IDF-definition – according to which in some populations a majority of subjects are diagnosed with the metabolic syndrome. BioMed Central 2007-09-06 /pmc/articles/PMC2031874/ /pubmed/17822558 http://dx.doi.org/10.1186/1475-2840-6-22 Text en Copyright © 2007 Moebus et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Moebus, Susanne
Hanisch, Jens Ulrich
Aidelsburger, Pamela
Bramlage, Peter
Wasem, Jürgen
Jöckel, Karl-Heinz
Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)
title Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_full Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_fullStr Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_full_unstemmed Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_short Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)
title_sort impact of 4 different definitions used for the assessment of the prevalence of the metabolic syndrome in primary healthcare:the german metabolic and cardiovascular risk project (gemcas)
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2031874/
https://www.ncbi.nlm.nih.gov/pubmed/17822558
http://dx.doi.org/10.1186/1475-2840-6-22
work_keys_str_mv AT moebussusanne impactof4differentdefinitionsusedfortheassessmentoftheprevalenceofthemetabolicsyndromeinprimaryhealthcarethegermanmetabolicandcardiovascularriskprojectgemcas
AT hanischjensulrich impactof4differentdefinitionsusedfortheassessmentoftheprevalenceofthemetabolicsyndromeinprimaryhealthcarethegermanmetabolicandcardiovascularriskprojectgemcas
AT aidelsburgerpamela impactof4differentdefinitionsusedfortheassessmentoftheprevalenceofthemetabolicsyndromeinprimaryhealthcarethegermanmetabolicandcardiovascularriskprojectgemcas
AT bramlagepeter impactof4differentdefinitionsusedfortheassessmentoftheprevalenceofthemetabolicsyndromeinprimaryhealthcarethegermanmetabolicandcardiovascularriskprojectgemcas
AT wasemjurgen impactof4differentdefinitionsusedfortheassessmentoftheprevalenceofthemetabolicsyndromeinprimaryhealthcarethegermanmetabolicandcardiovascularriskprojectgemcas
AT jockelkarlheinz impactof4differentdefinitionsusedfortheassessmentoftheprevalenceofthemetabolicsyndromeinprimaryhealthcarethegermanmetabolicandcardiovascularriskprojectgemcas